Floatz logo

Ribavirin

Handfoot-mouth Disease

Children's Hospital of Fudan UniversitySmall moleculePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Handfoot-mouth Disease cohort.

Asset / SponsorPhaseRating
Xiao'er jiebiao
Children's Hospital of Fudan University
Phase 4BB

Same molecule, other indications

Ribavirin is also rated in:

chronic hepatitis C virus infectionDormant
A
Indicative ·
82 / 100
View asset →
hepatitis C virus infectionDormant
A
Indicative ·
82 / 100
View asset →
cirrhosis of liverDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →